Year-over-year, this metric declined by 70.5%, from $749.00M to $221.00M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -7.0% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $256.00M | $748.00M | $758.00M | $1.91B | $921.00M | $617.00M | $250.00M | $241.00M | $0.00 | $511.00M | $233.00M | $4.00M | $352.00M | $250.00M | $256.00M | $749.00M | $478.00M | $89.00M | $0.00 | $221.00M |
| QoQ Change | — | +192.2% | +1.3% | +152.5% | -51.9% | -33.0% | -59.5% | -3.6% | -100.0% | — | -54.4% | -98.3% | >999% | -29.0% | +2.4% | +192.6% | -36.2% | -81.4% | -100.0% | — |
| YoY Change | — | — | — | — | +259.8% | -17.5% | -67.0% | -87.4% | -100.0% | -17.2% | -6.8% | -98.3% | — | -51.1% | +9.9% | >999% | +35.8% | -64.4% | -100.0% | -70.5% |